Gibraltar Industries closed on a $400 million five-year revolving credit facility. KeyBanc Capital Markets, Bank of America, M&T Bank and PNC Bank acted as joint lead arrangers for the new facility, with Comerica Bank, TD Bank and Wells Fargo serving as co-documentation agents.
According to an 8K filed with the SEC, Comerica Bank is serving as administrative agent, sole lead arranger and sole bookrunner for a $100 million revolving credit facility for Warby Parker, a retailer of eyewear. The facility also has a $75 million accordion, providing for a maximum of $175 million in funding.
Comercia Bank named Joe Ursuy executive vice president of national businesses for energy, renewables and waste. Ursuy most recently served as senior vice president and director of environmental services at Comerica, leading the bank’s environmental services department.
Comerica Bank named Corey Bailey executive vice president and head of middle-market and business banking. Bailey is a 25-year veteran of Comerica, previously serving as executive vice president of credit risk management and decisioning.
Archaea Energy obtained binding commitments from five financial institutions to amend its revolving credit and term loan agreement to, among other things, increase aggregate total commitments by approximately $450 million to a total of at least $920 million.
Group 1 Automotive completed a $2 billion five-year revolving syndicated credit facility with 21 financial institutions, including U.S. Bank, Bank of America and JPMorgan Chase.
Comerica Bank hired Jenae Anderson as head of commercial banking. At Comerica, Anderson will oversee commercial lending and community engagement while leading a team of lenders to expand the bank’s presence in Colorado.
Casella Waste Systems, a regional solid waste, recycling and resource management services company, entered into a $650 million amended and restated credit agreement with Bank of America as administrative agent and swing line lender.
Interpace Biosciences, along with its subsidiaries, entered into an $8 million term loan with BroadOak Fund V. Interpace Biosciences used the proceeds primarily to repay principal and interest on the $7.5 million short-term promissory notes due to the company’s two private equity stockholders.
Interpace Biosciences, along with its subsidiaries, entered into a $7.5 million revolving credit facility with Comerica Bank.